Drugs in R&D
Editor: Anton van Rensburg
ISSN: 1174-5886
(print version)
ISSN: 1179-6901
(electronic version)
Journal no. 40268
Articles published in Drugs in R&D may be accompanied by lay-level summaries, to assist patients, caregivers and others in understanding important medical advances.
The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.
Manuscripts submitted to the journal for publication will be subject to a $3,000 article processing charge (APC) upon acceptance. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.Related subjects » Adis
Abstracted/Indexed in
Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO Discovery Service, Academic OneFile, Academic Search, CSA Environmental Sciences, Expanded Academic, Health Reference Center Academic, Journals@OVID, OCLC, SCImago, Summon by ProQuest
Read this journal online
For authors and editors
-
Aims and Scope
Aims and Scope
CloseDrugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.
The Journal includes:
- Clinical research on new and established drugs;
- Preclinical research of direct relevance to clinical drug development;
- Short communications and case study reports that meet the above criteria will also be considered;
- Reviews may also be considered.
Articles published in Drugs in R&D may be accompanied by lay-level summaries, to assist patients, caregivers and others in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.
- Submit Online
-
Instructions for Authors
-
Important Information for Authors
- Disclosure of potential conflicts of int...
-
Copyright Information
Copyright Information
CloseCopyright and Licence Agreement
Open Access Drugs in R&D is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, go to: http://creativecommons. org/licenses/by-nc/4.0
Journal ownership: Springer International Publishing Switzerland
Copyright of articles: © The Author(s)
Services for the Journal
- Contacts
- Download Product Flyer
-
Shipping Dates
Shipping Dates
Close- 2017 2/17 21.05.17
- 2017 1/17 02.03.17
Alerts for this journal
Get the table of contents of every new issue published in Drugs in R&D.
Additional information
